Systematic Financial Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-9,255
| Closed | -$349K | – | 259 |
|
|
2020
Q2 | $349K | Sell |
9,255
-1,535
| -14% | -$57.9K | 0.02% | 204 |
|
|
2020
Q1 | $312K | Sell |
10,790
-590
| -5% | -$17.1K | 0.02% | 301 |
|
|
2019
Q4 | $590K | Buy |
11,380
+1,495
| +15% | +$77.5K | 0.02% | 367 |
|
|
2019
Q3 | $543K | Sell |
9,885
-13,275
| -57% | -$729K | 0.02% | 342 |
|
|
2019
Q2 | $941K | Sell |
23,160
-12,450
| -35% | -$506K | 0.04% | 325 |
|
|
2019
Q1 | $1.08M | Sell |
35,610
-1,875
| -5% | -$56.7K | 0.04% | 473 |
|
|
2018
Q4 | $1.26M | Buy |
+37,485
| New | +$1.26M | 0.04% | 287 |
|
|
2016
Q4 | – | Sell |
-50,200
| Closed | -$2.4M | – | 632 |
|
|
2016
Q3 | $2.4M | Sell |
50,200
-21,559
| -30% | -$1.03M | 0.03% | 324 |
|
|
2016
Q2 | $3.85M | Buy |
71,759
+34,640
| +93% | +$1.86M | 0.05% | 283 |
|
|
2016
Q1 | $1.66M | Sell |
37,119
-4,105
| -10% | -$183K | 0.02% | 433 |
|
|
2015
Q4 | $1.57M | Sell |
41,224
-18,640
| -31% | -$711K | 0.02% | 484 |
|
|
2015
Q3 | $1.91M | Sell |
59,864
-16,110
| -21% | -$513K | 0.02% | 518 |
|
|
2015
Q2 | $2.51M | Buy |
+75,974
| New | +$2.51M | 0.02% | 435 |
|
|
2014
Q3 | – | Sell |
-48,300
| Closed | -$2.24M | – | 675 |
|
|
2014
Q2 | $2.24M | Sell |
48,300
-592,827
| -92% | -$27.5M | 0.02% | 393 |
|
|
2014
Q1 | $26.4M | Buy |
641,127
+509,187
| +386% | +$20.9M | 0.18% | 139 |
|
|
2013
Q4 | $5.03M | Buy |
131,940
+68,770
| +109% | +$2.62M | 0.04% | 334 |
|
|
2013
Q3 | $1.51M | Buy |
+63,170
| New | +$1.51M | 0.01% | 462 |
|